Niacin/lovastatin
 | |
 | |
| Combination of | |
|---|---|
| Niacin | Lipid-lowering agent |
| Lovastatin | Statin |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| KEGG | |
  (what is this?) (verify) | |
Niacin/lovastatin (trade names Advicor, Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of the vitamin niacin and the statin drug lovastatin. The combination preparation is marketed by Abbott Laboratories.
It was approved by the FDA on December 17, 2001.
Dosage
The combination is available as tablets containing:[1]
- 500 mg/20 mg
- 750 mg/20 mg
- 1000 mg/20 mg
- 1000 mg/40 mg
References
- ↑ "Advicor package insert, How Supplied section". Retrieved 2008-03-15.
External links
- Advicor website
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.